Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Cancer Causes Control. 2013 May 17;24(8):1527–1534. doi: 10.1007/s10552-013-0229-6

Table 2.

Hazard ratios and 95% confidence intervals of prostate cancer by categories of coffee consumption in the NIH-AARP Diet and Health Study

Categories of total coffee intake
p-trend
None < 1 cup/day 1cup/day 2–3 cups/day 4–5 cups/day ≤6 cups/day
Total prostate cancer
n=23,335 2,136 3,894 3,781 9,835 2,902 787
 Age-adjusted HR 1.00 1.01 (0.96, 1.07) 0.96 (0.91, 1.01) 0.94 (0.89, 0.98) 0.91 (0.86, 0.96) 0.82 (0.76, 0.89) <0.0001
 Multivariate-adjusted HR 1.00 1.03 (0.98, 1.08) 1.00 (0.95, 1.06) 1.00 (0.96, 1.05) 1.00 (0.94, 1.06) 0.94 (0.87, 1.02) 0.08
Fatal prostate cancer
n=917 87 144 139 400 110 37
 Age-adjusted HR 1.00 0.89 (0.69, 1.17) 0.81 (0.62, 1.06) 0.90 (0.72, 1.14) 0.86 (0.65, 1.14) 1.02 (0.69, 1.49) 0.87
 Multivariate-adjusted HR 1.00 0.89 (0.68, 1.16) 0.81 (0.62, 1.06) 0.87 (0.69, 1.11) 0.77 (0.58, 1.03) 0.80 (0.53, 1.18) 0.20
Advanced prostate cancer
n= 2,927 264 510 440 1,185 401 127
 Age-adjusted HR 1.00 1.09 (0.94, 1.26) 0.93 (0.80, 1.08) 0.92 (0.81, 1.06) 1.01 (0.86,1.17) 1.04(0.84, 1.29) 0.56
 Multivariate-adjusted HR 1.00 1.10 (0.95, 1.28) 0.97 (0.83, 1.14) 0.98 (0.86, 1.12) 1.08 (0.92, 1.27) 1.15 (0.92, 1.43) 0.62
Nonadvanced prostate cancer
n=18,993 1,744 3,168 3,097 8,048 2,325 611
 Age-adjusted HR 1.00 1.01 (0.95, 1.07) 0.96 (0.90, 1.02) 0.94 (0.89, 0.99) 0.89 (0.84, 0.95) 0.78 (0.72, 0.86) <0.0001
 Multivariate-adjusted HR 1.00 1.03 (0.97, 1.09) 1.01 (0.95, 1.07) 1.01 (0.96, 1.07) 0.99 (0.93, 1.06) 0.92 (0.84, 1.01) 0.07

The multivariate models are adjusted for age, race, height, BMI, physical activity, smoking, history of diabetes, family history of prostate cancer, PSA testing, intakes of tomato sauce, alpha-linolenic acid and total energy intake.

Cases with missing stage are included in the total prostate cancer count but not in the subtypes.

Abbreviations: BMI, body mass index; HR, hazard ratio; NIH, National Institutes of Health; PSA, prostate specific antigen.